We are live on ! Find out more
TVTX icon

Travere Therapeutics
TVTX

81 hedge funds and large institutions have $735M invested in Travere Therapeutics in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

358% more call options, than puts

Call options by funds: $53.3M | Put options by funds: $11.6M

229% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 7

179% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 14

177% more capital invested

Capital invested by funds: $265M → $735M (+$470M)

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

25% more funds holding

Funds holding: 65 → 81 (+16)

Holders
81
Holders Change
+16
Holders Change %
+24.62%
% of All Funds
2.16%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.16%
New
23
Increased
39
Reduced
14
Closed
7
Calls
$53.3M
Puts
$11.6M
Net Calls
+$41.6M
Net Calls Change
+$38.1M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$18.5M
2
Millennium Management
Millennium Management
New York
+$14.3M
3
PA
Perceptive Advisors
New York
+$12.9M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$11.4M
5
RSCM
Rock Springs Capital Management
Maryland
+$10.7M

Top Sellers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
-$14.6M
2
OM
Opaleye Management
Massachusetts
-$6.4M
3
RTS
Round Table Services
New Jersey
-$3.29M
4
SAM
Senzar Asset Management
New York
-$2.39M
5
VAM
Visium Asset Management
New York
-$1.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$5.49M +$251K +16,472 +8%
Connor, Clark & Lunn Investment Management (CC&L)
27
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$4.38M +$660K +43,300 +31%
TI
28
Turner Investments
Pennsylvania
$4.07M -$909K -59,600 -26%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$4M +$576K +37,769 +29%
DM
30
Deerfield Management
New York
$3.79M +$2.41M +158,223 New
NCGI
31
Next Century Growth Investors
Minnesota
$3.71M +$2.36M +154,706 New
AA
32
AQR Arbitrage
Connecticut
$3.58M +$2.28M +149,500 New
VAM
33
Visium Asset Management
New York
$3.3M -$1.81M -118,712 -46%
Alyeska Investment Group
34
Alyeska Investment Group
Illinois
$3M +$1.91M +125,000 New
Bank of New York Mellon
35
Bank of New York Mellon
New York
$2.96M +$340K +22,317 +22%
SFM
36
Sphera Funds Management
Israel
$2.67M +$1.7M +111,392 New
TCIM
37
TIAA CREF Investment Management
New York
$2.38M +$147K +9,608 +11%
BIM
38
BlackRock Investment Management
Delaware
$1.91M +$291K +19,083 +31%
TI
39
Telemetry Investments
New York
$1.91M +$932K +61,100 +330%
Invesco
40
Invesco
Georgia
$1.67M +$1.06M +69,716 New
CS
41
Credit Suisse
Switzerland
$1.66M +$584K +38,326 +123%
BCM
42
Bridgeway Capital Management
Texas
$1.63M – – –
RTS
43
Round Table Services
New Jersey
$1.44M -$3.29M -215,852 -78%
Charles Schwab
44
Charles Schwab
California
$1.31M +$37.1K +2,436 +5%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$1.2M +$165K +10,800 +27%
MIM
46
Monashee Investment Management
Massachusetts
$1.2M +$762K +50,000 New
AQR Capital Management
47
AQR Capital Management
Connecticut
$1.2M +$142K +9,300 +23%
Citadel Advisors
48
Citadel Advisors
Florida
$1.04M +$321K +21,055 +94%
PP
49
PDT Partners
New York
$953K +$606K +39,759 New
D.E. Shaw & Co
50
D.E. Shaw & Co
New York
$951K -$90K -5,900 -13%
1
2
3 4

TVTX Hedge Fund Activity: Q1 2015 in Review

81 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Travere Therapeutics (TVTX) for Q1 2015, worth a combined $735M — up 177% from $265M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new TVTX positions and 7 closed out — a net gain of 16 holders — while 39 added to existing stakes and 14 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $18.5M. The largest seller was QVT Financial, cutting an estimated $14.6M.

  • 81 institutional investors held Travere Therapeutics (TVTX) as of Q1 2015, up from 65 in Q4 2014.
  • Funds reported $735M of Travere Therapeutics stock for Q1 2015, up 177% quarter-over-quarter.
  • 23 funds opened new Travere Therapeutics positions in Q1 2015 and 7 closed out, a net change of +16 holders.
  • The largest Travere Therapeutics buyer in Q1 2015 was Franklin Resources, an estimated $18.5M added.
  • The largest Travere Therapeutics seller in Q1 2015 was QVT Financial, an estimated $14.6M sold.

Based on aggregated 13F filings for Q1 2015.